Natural Products
| Catalog No. | Information |
| CFN95280 | Somnifericin |
| CFN95279 | N-trans-p-Coumaroyltyrosine |
| CFN95278 | Cannabiscitrin |
| CFN95277 | Quercetin 3-O-beta-D-glucosyl-(1->2)-rhamnoside |
| CFN95276 | Apigenin 4'-O-(2'',6''-di-O-E-p-coumaroyl)glucoside |
| CFN95275 | Daucoidin A |
| CFN95274 | 9-Hydroxy-O-senecioyl-8,9-dihydrooroselol |
| CFN95273 | Isoedultin |
| CFN95272 | Peucenidin |
| CFN95271 | Quercetin-3'-glucoside |
| CFN95270 | Aegineoside |
| CFN95269 | 2-Methoxy-1,4-naphthoquinone |
| CFN95268 | Cannabisin B Cannabisin B possesses considerable antiproliferative activity and that it may be utilised as a promising chemopreventive agent against hepatoblastoma disease. It induces autophagic cell death by inhibiting the AKT/mTOR pathway and S phase cell cycle arrest in HepG2 cell. |
| CFN95267 | Saucerneol Saucerneol has significant cardiovascular effects such as vasorelaxant and negative inotropic actions. |
| CFN95266 | Bidenoside C Bidenoside C may have hepatoprotective activity. |
| CFN95265 | N-trans-caffeoyltyramine N-trans-caffeoyltyramine is a novel and potent modulator of inflammatory responses. |
| CFN95264 | N-trans-caffeoyloctopamine N-trans-Caffeoyltyramine has both arginase inhibitory property and antioxidant capacity. |
| CFN95263 | Indolelactic acid Indolelactic acid is a phytochormone. |
| CFN95262 | 15-Deoxypulic acid Reference standards. |
| CFN95261 | 15-Methoxy-16-oxo-15,16H-strictic acid Reference standards. |
| CFN95260 | Phyllanthusiin C Reference standards. |
| CFN95259 | New compound 6 Reference standards. |
| CFN95258 | New compound 5 Reference standards. |
| CFN95257 | Vanillic acid glucoside Reference standards. |
| CFN95256 | N1,N5,N10-(E)-tri-p-coumaroylspermidine N1,N5,N10-(E)-tri-p-coumaroylspermidine shows free radical-scavenging activity. |
| CFN95255 | Safflospermidine A Safflospermidine A is a potential natural tyrosinase inhibitor,it shows high antityrosinase activity (IC50 of 13.8 μM）. |
| CFN95254 | Safflospermidine B Safflospermidine B is a potential natural tyrosinase inhibitor, it shows high antityrosinase activity (IC50 of 31.8μM). |
| CFN95253 | N1,N5,N10-(Z)-tri-p-coumaroylspermidine N1,N5,N10-(Z)-tri-p-coumaroylspermidine shows weak inhibition effect on [3H]-5-HT reuptake in rat brain synaptosomes. |
| CFN95252 | Vaccarin E Reference standards. |
| CFN95251 | Nortrachelogenin-5'-C-beta-glucoside Reference standards. |
| CFN95250 | (R)-O-isobutyroyllomatin (R)-O-isobutyroyllomatin shows significant dose-dependent protection against oxidative stress, it also exhibits cell proliferative effects. |
| CFN95249 | Vicinin 2 Reference standards. |
| CFN95248 | Quasipanaxatriol Quasipanaxatriol can greatly enhance the cytotoxicity of the anti-cancer drugs in P388/ADM cells. |
| CFN95247 | Chamigrenol Chamigrenol is a promising candidate for the development of potent Na+/K+ ATPase inhibitors and antimicrobial agents. It inhibited the activities of Na+/K+-ATPase, with the IC50 value of 15.9 ± 0.54 μg/mL. |
| CFN95246 | (-)-Cadin-4,10(15)-dien-11-oic acid Reference standards. |
| CFN95245 | Sphenanlignan Reference standards. |
| CFN95244 | Henricine Reference standards. |
| CFN95243 | Neoarctin B Reference standards. |
| CFN95242 | Lappaol B Reference standards. |
| CFN91840 | (+)-Mediresinol Di-O-beta-D-glucopyranoside Reference standards. |
| CFN91841 | Sibiricose A1 The sibiricosee A1, the sibiricose A5 and the tenuifoliside A have a better treatment function for tristimania caused by various reasons the sibiricose A5 and the tenuifoliside A have a certain protecting function for PC 12 cells damaged by glutamic acid and the sibiricosee A1, the sibiricose A5 and the tenuifoliside A all can shorten the tail-hanging resting time and the swim resting time of a mouse. |
| CFN91844 | Regaloside B Regaloside B can inhibit the expression of iNOS and COX-2. Regaloside B has anti-inflammatory activity. |
| CFN91852 | Regaloside A Regaloside A has anti-inflammatory activity. |
| CFN95241 | Polygalacin D2 Polygalacin D2 may have antimicrobial activity. |
| CFN95240 | Platycogenin A Reference standards. |
| CFN95239 | Gypenoside XIII Reference standards. |
| CFN95238 | 3-Acetyl-ginsenoside F1 Reference standards. |
| CFN70479 | Apioline Reference standards. |
| CFN70466 | Manassantin B Manassantin B is a potent inhibitor of NF-κB activation by the suppression of transciptional activity of RelA/p65 subunit of NF-κB. It also possesses anti-EBV lytic replication activity. Manassantin B inhibits interleukin-6-induced signal transducer and activator of transcription 3 activation in Hep3B cells, it has potential as a potent anti-inflammatory drug for use in pathological processes such as sepsis or acute lung injury. Manassantin B exerts antifibrotic activity in HSC-T6 cells, in part, via inhibition of cell proliferation and decrease of collagen production. |
| CFN70401 | 2',4'-Dihydroxydihydrochalcone 2',4'-Dihydroxydihydrochalcone has cytotoxic, and anti-inflammatory activities. |
